Introduction {#s1}
============

Dementia is one of the most serious health conditions affecting the world's elderly population \[[@r20], [@r51]\]. In 2012, 14% of elderly individuals (\>65 years of age) in Japan showed symptoms of dementia \[[@r20], [@r51]\]. This ratio is expected to increase to 20% in 2025 \[[@r20], [@r51]\]. More than 50% of dementia patients have Alzheimer's disease (AD) \[[@r20], [@r51]\]. Thus, AD is the most important disease target in dementia treatment.

AD has been investigated for more than 100 years. The initial symptom of AD is memory loss, the severity of which gradually increases with time; this is accompanied by disorientation and by disorder in the ability to make decisions \[[@r3], [@r4]\]. Dementia progresses steadily, with patients ultimately becoming bedridden \[[@r2]\]. Complications (such as pneumonia) develop over the course of 5--15 years, thus leading to a fatal outcome \[[@r14]\]. Its neuropathological characteristics, mainly amyloid plaques and neurofibrillary tangles, have been examined in the brains of AD patients \[[@r17], [@r24], [@r39]\]. Amyloid plaques are constructed from amyloid β (Aβ) 40 and 42 \[[@r40], [@r43]\]. Aβ42 is more aggregative than Aβ40 \[[@r18]\].

The viruses of *alphaherpesvirinae*, one of the three subfamilies of *herpesviridae*, persist in an inactive state, primarily in the neural tissues and mainly within the neurons of the ganglia, for varying durations \[[@r1], [@r42]\] and avoid the host's immune response \[[@r9], [@r32], [@r34], [@r41]\]. These latent viruses are often reactivated by stress \[[@r33], [@r34], [@r41]\]. Herpesvirus infection results in a long-term course of recurrent disease \[[@r46]\]. Thus, the establishment of latent infection is an interesting feature of all herpesviruses \[[@r46]\]. Animal models provide experimental systems that can be used to elucidate the molecular mechanisms of latent viral reactivation \[[@r46], [@r47]\].

Herpes simplex virus (HSV) is a member of the *alphaherpesvirinae* subfamily \[[@r22]\]. HSV infects humans and causes several diseases, including herpes labialis, corneal herpes, and herpes encephalitis \[[@r10]\]. Over the past 30 years, a large number of studies have reported a relationship between AD and HSV \[[@r5], [@r26], [@r33]\]. However, the mechanisms underlying this pathogenic association have not been fully clarified. In 2009, AD and HSV infection were suggested to be related \[[@r52]\]. It was also demonstrated that Aβ accumulated in cells and mouse brains infected with HSV type 1 \[[@r52]\]. However, it is unlikely that primary herpesvirus infection causes AD because dementia typically occurs in elderly patients who are likely to have already been infected with some type of herpesvirus; thus, latent infection should be considered.

We previously showed that latent pseudorabies virus (PRV) infection in swine was reactivated by treatment with acetylcholine both *in vivo* and *in vitro* \[[@r46]\]. We also established a model of latent PRV infection in BALB/c mice with YS-81, a wild-type strain of PRV \[[@r47]\]. Mice were pretreated with anti-PRV swine serum and then challenged with YS-81 based on a procedure described by Osorio and Rock \[[@r35]\]. Most mice survived, and PRV was detected and reactivated in the trigeminal ganglia (TG) of the mice. PRV was reactivated in latently infected (LI) mice *in vivo* following stimulation with acetylcholine \[[@r47]\].

We have been using our mouse model of latent PRV infection to study AD in mice with herpes virus infection. However, a great deal of time is required to obtain old mice. Various murine strains, including transgenic (Tg) mice, are used in the field of AD research \[[@r21], [@r36], [@r38], [@r41], [@r45], [@r50]\]. Some of these show accelerated senescence \[[@r36], [@r45], [@r50]\]. It may be possible to replace BALB/c mice with such models in our model of latent infection.

The senescence acceleration model (SAM) mouse, which was established by a Kyoto University group in 1981 \[[@r45]\], is a mouse model of senescence. We are attempting to establish an AD model with latent herpesvirus infection by establishing a model of latent pseudorabies virus infection using SAM mice. However, even when mouse strains that show accelerated senescence are used, they take 6 to 12 months to develop senility \[[@r44]\]. For scientific research, a short experimental period is more valuable because it allows a large number of results to be obtained. Thus, we need a mouse model that shows the characteristics of senility at an early stage.

The Tg2576 mouse is one of the most characterized and widely used mouse models in AD research \[[@r12]\]. It overexpresses a mutant form of APP (isoform 695) with the Swedish mutation, resulting in elevated levels of Aβ and ultimately amyloid plaques \[[@r21]\]. Some reports have shown that mice have impaired spatial learning, a working memory deficit and contextual fear conditioning at less than 6 months of age \[[@r36], [@r50]\]. On the other hand, mutations in the genes for APP or two homologous genes, presenilin-1 and presenilin-2 (PS1 and PS2), which produce components of the *γ*-secretase complex are linked to familial AD \[[@r37]\]. The PS2 mutations also enhance *γ*-secretase activity, leading to the increased production of Aβ42 \[[@r38]\]. Crossing of these mice resulted in a double Tg mouse (PS2Tg2576), which uniquely develops amyloid plaques \[[@r50]\]. Toda *et al.* demonstrated the early deposition of Aβ in PS2Tg2576 mice at 2--3 months of age and progressive accumulation in the brains of the mutant mice at 4--5 months of age \[[@r50]\].

With this background, we aimed to establish an AD model with latent herpesvirus infection by establishing a model of latent pseudorabies virus infection in double Tg mice and to examine the kinetics of Aβ in the brain.

Materials and Methods {#s2}
=====================

Animals
-------

Male APP Tg mice (Tg2576) were purchased from Taconic, Inc. (U.S.A.). Female PS2 Tg mice were purchased from Charles Laboratories Japan, Inc., and were used for the production of the PS2Tg2576 mice. Male C57BL/6 mice, which were used as controls, were purchased from Japan SLC, Inc.

Chemicals
---------

Acetylcholine chloride (ACH) was purchased from Wako Pure Chemical Industries, Ltd., Osaka, Japan.

Cells and viruses
-----------------

The YS-81 wild-type PRV strain \[[@r23]\], porcine kidney cells (PK-15) \[[@r19]\], and cloned porcine kidney cells (CPK) \[[@r16], [@r25]\] were gifts from Dr. Masashi Sakaguchi of the Chemo-Sero-Therapeutic Research Institute (Kaketsuken) in Kumamoto, Japan. The YS-81 strain was grown in PK-15, and the virus titer was assayed in CPK. The cells were grown in Eagle's minimum essential medium (MEM) containing 5% fetal bovine serum, 1.5% NaHCO~3,~ and 0.1% each of penicillin G potassium, streptomycin sulphate, and kanamycin sulphate.

Production of PS2Tg2576 mice
----------------------------

Two male Tg2576 mice and 4 female PS2 Tg mice were mated. At weaning of the juveniles, ear samples were harvested and stored at −20°C until a genotyping test was performed. The PS2Tg2576 mice were selected, and male mice were used for the latent infection test. We accidentally obtained second-generation PS2Tg2576 mice, and these mice were subjected to a genotyping test.

Genotyping test
---------------

The presence of knock-in genes in ear punch specimens was assessed by a PCR that amplified the target sequence. DNA was extracted from ear specimens of 1 mm in diameter using a MightyAmp Genotyping Kit (Takara Bio, Inc., Kusatsu, Shiga, Japan) in accordance with the manufacturer's protocol. For Tg2576 mice, the DNA samples and oligonucleotide primers were initially heated to 94°C for 2 min, denatured at 94°C for 1 min, annealed at 56°C for 1 min, and extended at 72°C for 2 min. The samples were then subjected to 30 cycles of amplification and maintained at 72°C for 7 min. For PS2 Tg mice, the DNA samples and oligonucleotide primers were initially heated to 94°C for 2 min, denatured at 94°C for 1 min, annealed at 56°C for 1 min, and extended at 72°C for 2 min. The samples were then subjected to 30 cycles of amplification and maintained at 72°C for 7 min. The forward primer sequence for Tg2576 was 5′-AGCGGTAGGACACACACACC-3′, and the reverse primer sequence was 5′-AGACGAGCACGACGATGTAC-3′. The forward primer sequence for PS2 Tg was 5′-AGCGGTAGGACACACACACC-3′, and the reverse primer sequence was 5′-AGACGAGCACGACGATGTAC-3′. The MightyAmp DNA Polymerase and MightyAmp Buffer in the MightyAmp Genotyping Kit were used for the DNA polymerase and buffer, respectively. The amplification products in 1.0% agarose gels were analyzed by electrophoresis.

Latent infection
----------------

Five-week-old mice were passively immunized by ip inoculation with 0.25 ml of anti-PRV swine serum (a gift from Dr. Sakaguchi, Kaketsuken). The final neutralization titer of this serum was 1:128. Thirty min later, the pre-immunized animals were infected ip with 100LD~50~ of YS-81. The LD~50~ of YS-81 against mice was determined by the method in our previous study \[[@r47]\]. Mice that survived the challenge were kept for 2 months and used as LI mice. The presence of PRV DNA in the TG of these LI mice was confirmed after they were euthanized \[[@r48]\].

Neutralizing test
-----------------

To determine the neutralization titer of anti-PRV swine serum, a neutralizing test was performed. CPK cells were cultured in 96-well microplates. Serial 2-fold dilutions of each serum sample were mixed with the YS-81 strain (200 TCID~50~/ml) and incubated at 37°C for 1 h. As a virus control, the virus solution was incubated in MEM without serum. Each mixture was added to cells in the microplates, and then the microplates were incubated at 37°C in 5% CO~2~. All wells were examined at days 7 and 11 to observe cytopathic effect appearance. The reciprocal of the highest dilution of the serum that inhibited a cytopathic effec was regarded as the neutralization titer.

Reactivation of latent PRV
--------------------------

The LI mice were intraperitoneally injected with 2.73 mg of ACH. As a control, PBS (the solvent of ACH) was intraperitoneally injected into LI mice.

Collection of nasal swab specimens
----------------------------------

During the study, nasal swab specimens were collected as previously described \[[@r15]\]. LI mice were anesthetized with Nembutal (Dainippon Pharmaceutical Co., Ltd., Japan), and 100 *µ*l of MEM was injected into one nasal cavity. The wash was collected from the other cavity and mouth with a swab (Men-tip, JCB Industry Limited, Tokyo, Japan); wash specimens were used as nasal swab specimens. The nasal swab specimens were immersed in 100 *µ*l of MEM and stored at −80°C until the virus isolation test. Nasal swab specimens were collected daily for 5 days after ACH stimulation.

Detection of viral DNA by PCR
-----------------------------

The presence of latent PRV DNA in nasal swab specimens was assessed by PCR amplification of a 531-bp target sequence in the gene encoding PRV gG \[[@r52]\]. DNA was extracted from the specimens with ISOGEN-LS (Wako Pure Chemical Industries, Ltd., Osaka, Japan), in accordance with the manufacturer's protocol. KOD FX Neo was used for DNA polymerase, and the PCR Buffer for KOD FX Neo (Toyobo Co., Ltd., Osaka, Japan) was used as a buffer. The DNA samples and oligonucleotide primers were initially heated to 94°C for 2 min, denatured at 94°C for 1 min, annealed at 56°C for 1 min, and extended at 72°C for 2 min. The samples were then subjected to 30 cycles of amplification and maintained at 72°C for 7 min. The forward primer sequence was 5′-AGCGGTAGGACACACACACC-3′, and the reverse primer sequence was 5′-AGACGAGCACGACGATGTAC-3′. The amplification products in 1.0% agarose gels were analyzed by electrophoresis.

Brain sample preparation
------------------------

Brain samples were collected after ACH stimulation. Approximately 200 *µ*g of brain tissue was minced, then 4 volumes of TBS was added, and then the mixture was homogenized. The homogenate was centrifuged at 15,000 RPM at 4°C for 15 min. The supernatant was collected to obtain soluble Aβ for an ELISA. Two volumes of TBS with 5 M guanidine was then added to the precipitate, and the samples were then sonicated for 15 min. Thereafter, the samples were centrifuged at 15,000 RPM at 4°C for 15 min, and the supernatant was collected to obtain insoluble Aβ for an ELISA.

Aβ detection
------------

A Human/Rat β Amyloid ELISA Kit *Wako* was used (Wako Pure Chemical Industries, Ltd., Osaka, Japan) in accordance with the manufacturer's protocol. The absorbance at 450 nm was measured in each well using an iMark^TM^ Microplate Absorbance Reader (Bio-Rad Laboratories, Tokyo, Japan). The Aβ concentration was determined from the standard curve.

Statistical analysis
--------------------

The significance of the differences in the Aβ concentrations of brain samples was analyzed using Student's *t*-test. The virus excretion data were analyzed using the chi-squared test.

Results {#s3}
=======

Production of PS2Tg2576 mice
----------------------------

The mating of 2 male Tg2576 mice and 4 female PS2 mice produced 105 juveniles. The juveniles were subjected to genotyping. The details of the production are shown in [Table 1](#tbl_001){ref-type="table"}Table 1.The numbers of juvenile Tg2576 male mice and PS2 Tg female miceDATE150107150228150407150423150730150804150909151008TotalTG25765714132831PS24528221125PS2Tg25764618212024Male2414111014Female2204101010Wild5623522025Total182462310879105Two Tg2576 male mice and 4 PS2 Tg female mice were mated. At weaning of the juveniles, ear samples were harvested and subjected to a genotyping test. The PS2Tg2576 mice were selected, and male mice were used for the latent infection test.. Fourteen male double Tg mice were obtained; 11 of them were used for the subsequent experiments.

Establishment of latent infection in PS2Tg2576 mice
---------------------------------------------------

The PS2Tg2576 mice were pre-immunized and infected with YS-81. All of the mice survived the challenge for 2 months (data not shown). They were then used as LI mice. The mice were intraperitoneally injected with ACH to reactivate the latent PRV.

Accumulation of Aβ in the brain after reactivation
--------------------------------------------------

The levels of Aβ in the brains of mice at two months after infection are shown in [Fig. 1](#fig_001){ref-type="fig"}Fig. 1.Amyloid β was detected by an ELISA in soluble and insoluble brain samples from double transgenic (Tg) mice at 2 months after latent infection and reactivation. The absorbance in each well was read at 450 nm, and the Aβ40 and Aβ42 concentrations were obtained from the standard curve. The significance of the differences in the concentrations of amyloid β in brain samples was analyzed by a *t*-test. \*Significant difference between latently infected and noninfected double Tg mice (*P\<*0.05). ^\#^Significant difference between latently infected double Tg mice and wild-type mice (*P\<*0.05).. The levels of soluble Aβ did not differ to a statistically significant extent among the tested groups; however, the level of insoluble-type Aβ in LI double Tg mice was significantly increased in comparison with the noninfected double Tg mice. A significant difference was also seen between LI double Tg mice and wild-type mice.

Virus excretion in nasal swabs
------------------------------

Nasal swab specimens were collected, and the presence of PRV DNA was confirmed by a PCR. As shown in [Table 2](#tbl_002){ref-type="table"}Table 2.Virus excretion in PS2Tg2576 mice latently infected with PRVStrainVirus infectionVirus excretionTotalChi-squared valueDay 1Day 2Day 3Day 4Day 5PositiveNegativePS2Tg2576Latently infected0/84/86/85/83/618200.001037511aNoninfected0/30/30/30/30/30150.000136546bC57BL/6Latently infected1/30/31/31/31/34110.168260983cData on virus excretion are shown as the number of mice that showed virus presence in nasal swabs by PCR. Total means the total number of mice that were positive or negative for virus presence in nasal swabs from Day 1 to Day 5. The chi-squared values were compared. a: The PS2Tg2576 latently infected group versus noninfected group. b: The PS2Tg2576 noninfected group versus the C57BL/6 latently infected group. c: The PS2Tg2576 latently infected group versus the C57BL/6 latently infected group., the viral DNA was identified. The nasal swab specimens were collected at the time of reactivation and were tested for the presence of PRV by a PCR. PRV reactivation was confirmed in the specimens collected daily for 5 days after ACH stimulation. The reactivation rates of the Tg and wild-type mice did not differ in this test. Viral DNA was not detected on day 0 (the day of reactivation; data not shown). We did not determine the threshold because this test was for quality, not for quantity.

Viral DNA in TG
---------------

The presence of PRV DNA in the TG of these LI mice was confirmed by PCR after the mice were euthanized (data not shown). The presence of PRV DNA in the TG of mice that were euthanized at 2 months after latent infection was proven by a PCR (data not shown).

Second-generation PS2Tg2576 mice
--------------------------------

We accidentally obtained second-generation PS2Tg2576 mice, and we performed genotyping on them. The gene derived from PS2 was determined. However, the gene derived from Tg2576 was found to have been dropped in the second generation of juveniles (data not shown).

Discussion {#s4}
==========

One hundred five juvenile mice were obtained in the present study, and 24 were PS2Tg2576 mice. The ratios of PS2, Tg2576, PS2Tg2576, and wild-type mice were almost the same and followed Mendel's law. This meant that there were no breeding problems.

By determining the PRV LD~50,~ the double Tg mice were latently infected in the same manner as BALB/c mice \[[@r47]\]. The viral LD~50~ of double Tg mice was similar to that of C57BL/6 mice, the background strain of the Tg2576 and PS2 Tg mice, as shown in our previous report \[[@r49]\]. A latent infection model was constructed by inoculating the mice with 100 LD~50~ of PRV YS-81. This means that our mouse model can be widely applied in life science research because it can be applied to many types of Tg mice that descend from C57BL/6 mice. Virus reactivation was observed in LI double Tg mice, as was observed in other strains \[[@r49]\]. It was determined that latent PRV infection was established in the PS2Tg2576 mice.

The results showed that accumulation of insoluble Aβ was increased in the brain of PS2Tg2576 mice with the reactivation of latent PRV but not in uninfected PS2Tg2576 mice or LI C57BL/6 mice ([Fig. 1](#fig_001){ref-type="fig"}).

As shown in [Fig. 1](#fig_001){ref-type="fig"}, the reactivation group showed significantly higher levels of insoluble Aβ, which indicates that reactivation of LI herpesvirus might cause the severity of AD to increase \[[@r6], [@r13]\].

There is a limitation of the present model, and it would be better to combine the present model with other models to evaluate the disease symptoms. If the present model is used, it might be necessary to increase the study period by a number of months in order to identify typical behaviors. The increase in the accumulation of Aβ that was typically observed in this model appeared after only two months; thus, PS2Tg2576 mice can be used to investigate the accumulation of Aβ in the brain in dementia research. This short-term study shows the merit of the PS2Tg2576 mouse model.

In the present study, we accidentally obtained second-generation PS2Tg2576 mice. The gene derived from Tg2576 was found to have been dropped in the second generation of juveniles (data not shown). The reason for this was not clear; however, this result indicates that PS2 and Tg2576 mice should be mated for each test in order to obtain PS2Tg2576 mice. This might be a barrier to research.

In the present study, PRV was used to establish latent herpesvirus infection in our mouse model. HSV belongs to the Simplexvirus genus, while PRV belongs to the Varicellovirus genus, which includes varicella zoster virus \[[@r22]\]. Although the relationship between HSV and AD has been reported, a few studies have suggested a relationship between varicella zoster virus and AD \[[@r11], [@r28],[@r29],[@r30]\]. It seems to depend on the affinity to the brain; however, we do not have any data on this. PRV has high affinity to the brain and is used as a tracer in the brain via the nervous system \[[@r8], [@r9]\].

There are some reports on models of latent HSV infection \[[@r7], [@r27]\]; however, in these studies, the researchers only harvested ganglia that were latently infected with HSV and reactivated the virus *in vitro* \[[@r31], [@r53]\]. On the other hand, we could reactivate the latent virus *in vivo* in our model of latent PRV infection \[[@r47]\]. Our model offers an advantage in that we could observe the dynamism in the mouse brain during the reactivation of latent PRV.

In this report, we showed that PS2Tg2576 mice were useful to a limited extent for the analysis of AD in an experimental mouse model with latent herpesvirus infection, which was ready for use after only two months. This model will be useful for assessing AD in the early experimental period.
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